Guidance for Practicing Primary Care

Clinical Guidelines: Testosterone therapy in men with hypogonadism


 

Treatment

In patients found to have low testosterone with signs and symptoms of testosterone deficiency, testosterone therapy is recommended to induce and maintain secondary sex characteristics and correct the symptoms of testosterone deficiency. Testosterone-replacement therapy in men with low testosterone levels leads to a small but statistically significant improvement in libido, erectile function, sexual activity or satisfaction, muscle mass, and bone density but does not lead to improvements in energy and mood.

Testosterone replacement should not be done in patient’s planning fertility in the near future, those with prostate or breast cancer, a palpable prostate nodule, a prostate-specific antigen (PSA) level greater than 4 ng/mL, a PSA greater than 3 ng/mL with high risk for prostate cancer, high hematocrit, untreated obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, MI or stroke within the last 6 months, or thrombophilia.

In men undergoing therapy, there is a higher frequency of erythrocytosis (hematocrit greater than 54%; relative risk, 8.14) but no increase in lower urinary tract symptoms. The benefit and risk of regular prostate cancer screening should be discussed prior to starting therapy with men aged 40-69 years with an increased risk of prostate cancer and with all men aged 55-69 years. For those who desire prostate cancer screening, PSA levels should be checked prior to starting therapy, and a digital prostate examination should be done at baseline and at 3-12 months after starting testosterone treatment. After 1 year, prostate cancer screening can be done per standard guidelines.

The decision about therapy in men older than 65 years is challenging because testosterone levels normally decline with age. It is not necessary to prescribe testosterone routinely to men older than 65 years with only low testosterone, and treatment should be reserved for those with symptoms along with low testosterone concentrations.

Men with HIV with low testosterone concentrations and weight loss can be treated with testosterone to induce and maintain body weight and lean muscle mass.

Recommended Reading

Free testosterone linked to frailty in older men
MDedge Family Medicine
Without reliability, testosterone testing may fall short
MDedge Family Medicine
VIDEO: Researchers closing in on the elusive ‘male pill’
MDedge Family Medicine
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Family Medicine
Sexual harassment, violence is our problem, too
MDedge Family Medicine
Declining androgen levels correlated with increased frailty
MDedge Family Medicine
MDedge Daily News: Can androgen therapy improve male frailty?
MDedge Family Medicine
VIDEO: Poorer cardiometabolic health seen in men with low sperm count
MDedge Family Medicine
Zika virus: Sexual contact risk may be limited to short window
MDedge Family Medicine
Transgender women on HT have lower bone density, more fat mass than men
MDedge Family Medicine